FI965289A - DP-1:n ja muiden DP-proteiinien estäjien määritys - Google Patents

DP-1:n ja muiden DP-proteiinien estäjien määritys Download PDF

Info

Publication number
FI965289A
FI965289A FI965289A FI965289A FI965289A FI 965289 A FI965289 A FI 965289A FI 965289 A FI965289 A FI 965289A FI 965289 A FI965289 A FI 965289A FI 965289 A FI965289 A FI 965289A
Authority
FI
Finland
Prior art keywords
pct
phosphorylation
sec
date
determination
Prior art date
Application number
FI965289A
Other languages
English (en)
Swedish (sv)
Other versions
FI965289A0 (fi
Inventor
Thangue Nicholas Barrie La
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of FI965289A0 publication Critical patent/FI965289A0/fi
Publication of FI965289A publication Critical patent/FI965289A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI965289A 1994-07-01 1996-12-31 DP-1:n ja muiden DP-proteiinien estäjien määritys FI965289A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9413327A GB9413327D0 (en) 1994-07-01 1994-07-01 Assay for inhibitors of dp-1
PCT/GB1995/001567 WO1996001425A2 (en) 1994-07-01 1995-07-03 Assay for inhibitors of dp-1 and other dp proteins

Publications (2)

Publication Number Publication Date
FI965289A0 FI965289A0 (fi) 1996-12-31
FI965289A true FI965289A (fi) 1996-12-31

Family

ID=10757696

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965289A FI965289A (fi) 1994-07-01 1996-12-31 DP-1:n ja muiden DP-proteiinien estäjien määritys

Country Status (13)

Country Link
US (1) US5871901A (fi)
EP (1) EP0769144B1 (fi)
JP (1) JPH10502252A (fi)
AT (1) ATE186119T1 (fi)
AU (1) AU698473B2 (fi)
CA (1) CA2193091A1 (fi)
DE (2) DE769144T1 (fi)
DK (1) DK0769144T3 (fi)
FI (1) FI965289A (fi)
GB (1) GB9413327D0 (fi)
NO (1) NO317397B1 (fi)
NZ (1) NZ288712A (fi)
WO (1) WO1996001425A2 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127505A (en) * 1995-02-02 2000-10-03 Simula Inc. Impact resistant polyurethane and method of manufacture thereof
GB9610195D0 (en) * 1996-05-15 1996-07-24 Medical Res Council Assay
US6159691A (en) * 1996-05-15 2000-12-12 Prolifix Limited Assay for a putative regulator of cell cycle progression
US6713449B1 (en) * 1996-09-30 2004-03-30 Kyowa Hakko Kogyo Co., Ltd. E2F activity inhibitory compounds
US6387649B1 (en) 1996-09-30 2002-05-14 Prolifix Limited Assay for a regulator of cell cycle progression
WO1999053075A2 (en) * 1998-04-09 1999-10-21 E.I. Du Pont De Nemours And Company Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants
GB0308711D0 (en) * 2003-04-15 2003-05-21 Univ The Glasgow Assay methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ257181A (en) * 1992-10-29 1997-07-27 Medical Res Council Transcription factor dp-1, dna, vectors and host cells therefor
JPH08508009A (ja) * 1993-02-12 1996-08-27 ザ ソーク インスティチュート フォア バイオロジカル スタディーズ 転写因子、特にｃｒｅｂ誘導ペプチドに対するホスホ特異的抗体

Also Published As

Publication number Publication date
DK0769144T3 (da) 2000-05-08
JPH10502252A (ja) 1998-03-03
ATE186119T1 (de) 1999-11-15
EP0769144B1 (en) 1999-10-27
NO965584D0 (no) 1996-12-27
WO1996001425A2 (en) 1996-01-18
GB9413327D0 (en) 1994-08-24
FI965289A0 (fi) 1996-12-31
EP0769144A2 (en) 1997-04-23
WO1996001425A3 (en) 1996-03-14
DE69513025D1 (de) 1999-12-02
AU2803695A (en) 1996-01-25
NZ288712A (en) 1998-09-24
AU698473B2 (en) 1998-10-29
DE769144T1 (de) 1997-07-10
US5871901A (en) 1999-02-16
DE69513025T2 (de) 2000-04-13
CA2193091A1 (en) 1996-01-18
NO965584L (no) 1997-02-28
NO317397B1 (no) 2004-10-25

Similar Documents

Publication Publication Date Title
DE69104491D1 (de) Bestimmung von glycosilierten blutproteinen.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
DE69115267D1 (de) Antigen-/antiantigenspaltung.
ES2102007T3 (es) Proteinas de fusion de fragmentos de anticuerpo monomeras y dimeras.
TR199901696T2 (xx) Monoklonal veya poliklonal antikorlara ili�kin sabit liyofillenmi� farmakolojik terkipler.
IL130403A (en) Oil bodies and associated proteins as affinity matrices
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
FI965289A (fi) DP-1:n ja muiden DP-proteiinien estäjien määritys
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
DE69412940D1 (de) Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
DE69729056D1 (de) Verfahren zur Detektion von Ausgangsfluktuationen bei Verbrennungsmotoren
WO2000018909A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM)
DE69606024D1 (de) Feststellung von antikörperproduktion
GB2214295B (en) "hapten determination method, use and components"
DK1031035T3 (da) Haptoglobin assay
DE59708783D1 (de) Diagnosehilfe sowie verfahren zum nachweis der trächtigkeit von wiederkäuern
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
KR890702037A (ko) 간장암 질환의 진단법
SE9203159D0 (sv) Partikel suspension

Legal Events

Date Code Title Description
FD Application lapsed